Moreover, oxidative phosphorylation, estrogen receptor signaling, hepatic fibrosis signaling, IL-8 signaling were found to be activated in tumors, whereas PD-L1 cancer immunotherapy pathway, the antioxidant action of vitamin C, PTEN signaling and PPAR signaling were inhibited (Fig. 3d). This evidence concerns the gene CXCL8 and cancer.